/ Regulatory Dispatch Index

Monograph updates and compliance dispatches

Official notifications regarding EDQM dossier approvals, US FDA filings, and global pharmacopeial harmonisation milestones for active pharmaceutical ingredients.

Recent Filings

Institutional updates and facility milestones

Timed releases tracking international export compliance and analytical testing infrastructure expansions.

October 2023
September 2023
August 2023

CEP dossier renewals granted for micronised API grades

Cold-chain terminal expansion at Antwerp logistics zone

Analytical laboratory assay precision enhancements

EDQM has officially renewed Certificates of Suitability across our primary anti-infective and cardiovascular API powder categories.

Upgraded temperature-controlled transit facilities now guarantee continuous 2-8°C cold-chain monitoring for global biologic intermediates.

Integration of advanced high-performance liquid chromatography columns improves impurity profiling detection limits across all active batches.

Technical Briefing

USP particle-size distribution guidelines

Recent revisions to United States Pharmacopeia chapters mandate stricter laser diffraction tolerances for inhalation and parenteral API formulations. Our quality assurance teams have updated dispersion protocols to verify D90 and D50 parameters across all export lots, ensuring complete audit readiness for destination formulators.

Formulation scientists reviewing monograph adjustments can access comprehensive validation packages through our secure technical portal. Each dossier includes complete batch release data, residual solvent profiles, and certified reference standards to support seamless regulatory filing.

Receive verified regulatory alerts directly to your QA team

Stay informed on pharmacopeial revisions and shipping capacity updates.